JBF Capital’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-132,702
Closed -$114K 98
2019
Q4
$114K Buy
+132,702
New +$102K 0.02% 61

JBF Capital's GCVRZ Position: Q1 2020 in Review

JBF Capital sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 132,702 shares — an estimated $114K sold.

JBF Capital first reported a position in GCVRZ in Q4 2019 and held it in 1 quarter. The position peaked at $114K in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • JBF Capital reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • JBF Capital sold 132,702 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $114K.
  • JBF Capital first reported a position in Sanofi Contingent Value Rights in Q4 2019 and held it in 1 quarter.
  • JBF Capital's Sanofi Contingent Value Rights position peaked at $114K in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on JBF Capital's 13F filing for Q1 2020, filed 15 May 2020.